[Early appearance of myelodysplastic syndrome secondary to therapy for Burkitt-type acute lymphoblastic leukemia (ALL3)]
Sangre (Barc)
.
1999 Feb;44(1):81-2.
[Article in Spanish]
Authors
M Sánchez
,
T Orero
,
J M Marco
,
A Miguel
PMID:
10323104
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Antineoplastic Agents / adverse effects
Burkitt Lymphoma / complications
Burkitt Lymphoma / drug therapy*
Fatal Outcome
Humans
Male
Myelodysplastic Syndromes / etiology*
Prognosis
Time Factors
Substances
Antineoplastic Agents